| Cayman Islands | 001-34775 | 98-1228572 | ||||||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
||||||
| Title of each class | Trading Symbol(s) |
Name of each exchange on which registered |
||||||||||||
| Ordinary Shares, $0.01 par value | FN | New York Stock Exchange | ||||||||||||
| Exhibit No. | Description | |||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
| FABRINET | ||||||||
| By: | /s/ CSABA SVERHA | |||||||
| Csaba Sverha | ||||||||
| Executive Vice President, Chief Financial Officer | ||||||||
Date: May 5, 2025 |
||||||||
| What: | Fabrinet Third Quarter Fiscal Year 2025 Financial Results Call |
|||||||
| When: | May 5, 2025 |
|||||||
| Time: | 5:00 p.m. ET | |||||||
| Live Call and Replay: | https://investor.fabrinet.com/events-and-presentations/events |
|||||||
| (in thousands of U.S. dollars, except share data and par value) | March 28, 2025 |
June 28, 2024 |
|||||||||
| (unaudited) | |||||||||||
| Assets | |||||||||||
| Current assets | |||||||||||
| Cash and cash equivalents | $ | 306,905 | $ | 409,973 | |||||||
| Short-term investments | 643,772 | 448,630 | |||||||||
| Trade accounts receivable, net of allowance for expected credit losses of $1,255 and $1,629, respectively | 658,301 | 592,452 | |||||||||
| Inventories | 531,338 | 463,206 | |||||||||
| Prepaid expenses | 19,396 | 10,620 | |||||||||
| Other current assets | 84,731 | 87,810 | |||||||||
| Total current assets | 2,244,443 | 2,012,691 | |||||||||
| Non-current assets | |||||||||||
| Property, plant and equipment, net | 354,489 | 307,240 | |||||||||
| Intangibles, net | 2,173 | 2,321 | |||||||||
| Operating right-of-use assets | 6,021 | 5,336 | |||||||||
| Deferred tax assets | 11,589 | 10,446 | |||||||||
| Other non-current assets | 586 | 485 | |||||||||
| Total non-current assets | 374,858 | 325,828 | |||||||||
| Total Assets | $ | 2,619,301 | $ | 2,338,519 | |||||||
| Liabilities and Shareholders’ Equity | |||||||||||
| Current liabilities | |||||||||||
| Trade accounts payable | 521,226 | 441,835 | |||||||||
| Fixed assets payable | 33,101 | 14,380 | |||||||||
| Operating lease liabilities, current portion | 1,709 | 1,355 | |||||||||
| Income tax payable | 8,090 | 3,937 | |||||||||
| Accrued payroll, bonus and related expenses | 24,170 | 22,116 | |||||||||
| Accrued expenses | 32,420 | 19,916 | |||||||||
| Other payables | 54,331 | 54,403 | |||||||||
| Total current liabilities | 675,047 | 557,942 | |||||||||
| Non-current liabilities | |||||||||||
| Deferred tax liability | 1,371 | 4,895 | |||||||||
| Operating lease liability, non-current portion | 4,012 | 3,635 | |||||||||
| Severance liabilities | 28,337 | 24,093 | |||||||||
| Other non-current liabilities | 3,340 | 2,209 | |||||||||
| Total non-current liabilities | 37,060 | 34,832 | |||||||||
| Total Liabilities | 712,107 | 592,774 | |||||||||
| Shareholders’ equity | |||||||||||
Preferred shares (5,000,000 shares authorized, $0.01 par value; no shares issued and outstanding as of March 28, 2025 and June 28, 2024) |
— | — | |||||||||
Ordinary shares (500,000,000 shares authorized, $0.01 par value; 39,596,609 shares and 39,457,462 shares issued as of March 28, 2025 and June 28, 2024, respectively; and 35,830,476 shares and 36,145,242 shares outstanding as of March 28, 2025 and June 28, 2024, respectively) |
396 | 395 | |||||||||
| Additional paid-in capital | 229,957 | 222,044 | |||||||||
| Less: Treasury shares (3,766,133 shares and 3,312,220 shares as of March 28, 2025 and June 28, 2024, respectively) | (337,798) | (234,323) | |||||||||
| Accumulated other comprehensive income (loss) | 8,549 | (3,141) | |||||||||
| Retained earnings | 2,006,090 | 1,760,770 | |||||||||
| Total Shareholders’ Equity | 1,907,194 | 1,745,745 | |||||||||
| Total Liabilities and Shareholders’ Equity | $ | 2,619,301 | $ | 2,338,519 | |||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (in thousands of U.S. dollars, except per share data) | March 28, 2025 |
March 29, 2024 |
March 28, 2025 |
March 29, 2024 |
|||||||||||||||||||
| Revenues | $ | 871,799 | $ | 731,535 | $ | 2,509,635 | $ | 2,129,706 | |||||||||||||||
| Cost of revenues | (769,616) | (640,600) | (2,207,577) | (1,866,037) | |||||||||||||||||||
| Gross profit | 102,183 | 90,935 | 302,058 | 263,669 | |||||||||||||||||||
| Selling, general and administrative expenses | (22,063) | (19,628) | (65,300) | (59,373) | |||||||||||||||||||
| Restructuring and other related costs | (1,264) | — | (1,367) | — | |||||||||||||||||||
| Operating income | 78,856 | 71,307 | 235,391 | 204,296 | |||||||||||||||||||
| Interest income | 10,145 | 8,509 | 32,392 | 22,155 | |||||||||||||||||||
| Interest expense | — | (26) | — | (107) | |||||||||||||||||||
| Foreign exchange gain (loss), net | (2,675) | 3,348 | (5,728) | (25) | |||||||||||||||||||
| Other income (expense), net | (30) | 175 | (111) | 60 | |||||||||||||||||||
| Income before income taxes | 86,296 | 83,313 | 261,944 | 226,379 | |||||||||||||||||||
| Income tax expense | (5,006) | (2,397) | (16,624) | (11,264) | |||||||||||||||||||
| Net income | 81,290 | 80,916 | 245,320 | 215,115 | |||||||||||||||||||
| Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
| Change in net unrealized gain (loss) on available-for-sale securities | 3,350 | (1,739) | 9,647 | 2,155 | |||||||||||||||||||
| Change in net unrealized gain (loss) on derivative instruments | 1,790 | (7,328) | 907 | 1,062 | |||||||||||||||||||
| Change in net retirement benefits plan – prior service cost | — | 137 | — | 271 | |||||||||||||||||||
| Change in foreign currency translation adjustment | 1,060 | 75 | 1,136 | (31) | |||||||||||||||||||
| Total other comprehensive income (loss), net of tax | 6,200 | (8,855) | 11,690 | 3,457 | |||||||||||||||||||
| Net comprehensive income | $ | 87,490 | $ | 72,061 | $ | 257,010 | $ | 218,572 | |||||||||||||||
| Earnings per share | |||||||||||||||||||||||
| Basic | $ | 2.26 | $ | 2.23 | $ | 6.80 | $ | 5.93 | |||||||||||||||
| Diluted | $ | 2.25 | $ | 2.21 | $ | 6.75 | $ | 5.88 | |||||||||||||||
| Weighted-average number of ordinary shares outstanding (in thousands of shares) | |||||||||||||||||||||||
| Basic | 35,914 | 36,250 | 36,094 | 36,278 | |||||||||||||||||||
| Diluted | 36,172 | 36,603 | 36,327 | 36,574 | |||||||||||||||||||
| Nine Months Ended | |||||||||||
| (in thousands of U.S. dollars) | March 28, 2025 |
March 29, 2024 |
|||||||||
| Cash flows from operating activities | |||||||||||
| Net income for the period | $ | 245,320 | $ | 215,115 | |||||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||||||||
| Depreciation and amortization | 39,223 | 36,602 | |||||||||
| (Gain) loss on disposal of property, plant and equipment and intangibles | (39) | (147) | |||||||||
| Amortization of discount (premium) of short-term investments | (3,435) | (2,317) | |||||||||
| (Reversal of) allowance for expected credit losses | (374) | 1,874 | |||||||||
| Unrealized loss (gain) on exchange rate and fair value of foreign currency forward contracts | 4,067 | (2,135) | |||||||||
| Amortization of fair value at hedge inception of interest rate swaps | — | (198) | |||||||||
| Share-based compensation | 24,903 | 21,440 | |||||||||
| Customer warrant | 3,929 | — | |||||||||
| Deferred income tax expense (benefit) | (4,182) | 1,125 | |||||||||
| Other non-cash expenses | 82 | 193 | |||||||||
| Changes in operating assets and liabilities | |||||||||||
| Trade accounts receivable | (65,271) | (54,089) | |||||||||
| Inventories | (68,132) | 65,442 | |||||||||
| Other current assets and non-current assets | (2,357) | (33,548) | |||||||||
| Trade accounts payable | 79,196 | 48,268 | |||||||||
| Income tax payable | 4,180 | (1,068) | |||||||||
| Accrued expenses | 12,643 | 1,493 | |||||||||
| Other payables | (152) | 29,309 | |||||||||
| Severance liabilities | 2,131 | 2,249 | |||||||||
| Other current liabilities and non-current liabilities | 1,540 | 476 | |||||||||
| Net cash provided by operating activities | 273,272 | 330,084 | |||||||||
| Cash flows from investing activities | |||||||||||
| Purchase of short-term investments | (304,189) | (268,461) | |||||||||
| Proceeds from sales of short-term investments | — | 10,000 | |||||||||
| Proceeds from maturities of short-term investments | 122,129 | 173,120 | |||||||||
| Purchase of property, plant and equipment | (70,668) | (34,825) | |||||||||
| Purchase of intangibles | (514) | (768) | |||||||||
| Proceeds from disposal of property, plant and equipment | 116 | 2,319 | |||||||||
| Net cash used in investing activities | (253,126) | (118,615) | |||||||||
| Cash flows from financing activities | |||||||||||
| Repayment of long-term borrowings | — | (9,141) | |||||||||
| Repurchase of ordinary shares | (103,475) | (35,943) | |||||||||
| Withholding tax related to net share settlement of restricted share units | (20,918) | (12,716) | |||||||||
| Net cash used in financing activities | (124,393) | (57,800) | |||||||||
| Net increase (decrease) in cash and cash equivalents | $ | (104,247) | $ | 153,669 | |||||||
| Movement in cash and cash equivalents | |||||||||||
| Cash and cash equivalents at the beginning of period | $ | 409,973 | $ | 231,368 | |||||||
| Increase (decrease) in cash and cash equivalents | (104,247) | 153,669 | |||||||||
| Effect of exchange rate on cash and cash equivalents | 1,179 | 74 | |||||||||
| Cash and cash equivalents at the end of period | $ | 306,905 | $ | 385,111 | |||||||
| Non-cash investing and financing activities | |||||||||||
| Construction, software and equipment-related payables | $ | 33,101 | $ | 9,229 | |||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
| (in thousands of U.S. dollars) | March 28, 2025 |
March 29, 2024 |
March 28, 2025 |
March 29, 2024 |
|||||||||||||||||||||||||||||||||||||||||||
| Revenues | $ | 871,799 | $ | 731,535 | $ | 2,509,635 | $ | 2,129,706 | |||||||||||||||||||||||||||||||||||||||
| Gross profit (GAAP) | $ | 102,183 | 11.7 | % | $ | 90,935 | 12.4 | % | $ | 302,058 | 12.0 | % | $ | 263,669 | 12.4 | % | |||||||||||||||||||||||||||||||
| Share-based compensation expenses | 2,221 | 1,561 | 7,883 | 5,427 | |||||||||||||||||||||||||||||||||||||||||||
| Gross profit (Non-GAAP) | $ | 104,404 | 12.0 | % | $ | 92,496 | 12.6 | % | $ | 309,941 | 12.4 | % | $ | 269,096 | 12.6 | % | |||||||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
| (in thousands of U.S. dollars) | March 28, 2025 |
March 29, 2024 |
March 28, 2025 |
March 29, 2024 |
|||||||||||||||||||||||||||||||||||||||||||
| Revenues | $ | 871,799 | $ | 731,535 | $ | 2,509,635 | $ | 2,129,706 | |||||||||||||||||||||||||||||||||||||||
| Operating profit (GAAP) | $ | 78,856 | 9.0 | % | $ | 71,307 | 9.7 | % | $ | 235,391 | 9.4 | % | $ | 204,296 | 9.6 | % | |||||||||||||||||||||||||||||||
| Share-based compensation expenses | 7,783 | 6,726 | 24,903 | 21,440 | |||||||||||||||||||||||||||||||||||||||||||
| Restructuring and other related costs | 1,264 | — | 1,367 | — | |||||||||||||||||||||||||||||||||||||||||||
| Legal and litigation | 827 | — | 827 | — | |||||||||||||||||||||||||||||||||||||||||||
| Severance payment and others | — | — | 748 | — | |||||||||||||||||||||||||||||||||||||||||||
| Operating profit (Non-GAAP) | $ | 88,730 | 10.2 | % | $ | 78,033 | 10.7 | % | $ | 263,236 | 10.5 | % | $ | 225,736 | 10.6 | % | |||||||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
| March 28, 2025 |
March 29, 2024 |
March 28, 2025 |
March 29, 2024 |
||||||||||||||||||||||||||||||||||||||||||||
| (in thousands of U.S. dollars, except per share data) | Net income | Diluted EPS | Net income | Diluted EPS | Net income | Diluted EPS | Net income | Diluted EPS | |||||||||||||||||||||||||||||||||||||||
| GAAP measures | $ | 81,290 | $ | 2.25 | $ | 80,916 | $ | 2.21 | $ | 245,320 | $ | 6.75 | $ | 215,115 | $ | 5.88 | |||||||||||||||||||||||||||||||
| Items reconciling GAAP net income & EPS to non-GAAP net income & EPS: | |||||||||||||||||||||||||||||||||||||||||||||||
| Related to cost of revenues: | |||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expenses | 2,221 | 0.06 | 1,561 | 0.04 | 7,883 | 0.22 | 5,427 | 0.15 | |||||||||||||||||||||||||||||||||||||||
| Total related to cost of revenues | 2,221 | 0.06 | 1,561 | 0.04 | 7,883 | 0.22 | 5,427 | 0.15 | |||||||||||||||||||||||||||||||||||||||
| Related to selling, general and administrative expenses: | |||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expenses | 5,562 | 0.16 | 5,165 | 0.14 | 17,020 | 0.47 | 16,013 | 0.44 | |||||||||||||||||||||||||||||||||||||||
| Legal and litigation | 827 | 0.02 | — | — | 827 | 0.02 | — | — | |||||||||||||||||||||||||||||||||||||||
| Severance payment and others | — | — | — | — | 748 | 0.02 | — | — | |||||||||||||||||||||||||||||||||||||||
| Total related to selling, general and administrative expenses | 6,389 | 0.18 | 5,165 | 0.14 | 18,595 | 0.51 | 16,013 | 0.44 | |||||||||||||||||||||||||||||||||||||||
| Related to other income and expense: | |||||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and other related costs | 1,264 | 0.03 | — | — | 1,367 | 0.04 | — | — | |||||||||||||||||||||||||||||||||||||||
| Amortization of deferred debt issuance costs | — | — | 8 | 0.00 | — | — | 24 | 0.00 | |||||||||||||||||||||||||||||||||||||||
| Total related to other income and expense | 1,264 | 0.03 | 8 | 0.00 | 1,367 | 0.04 | 24 | 0.00 | |||||||||||||||||||||||||||||||||||||||
| Total related to net income & EPS | 9,874 | 0.27 | 6,734 | 0.18 | 27,845 | 0.77 | 21,464 | 0.59 | |||||||||||||||||||||||||||||||||||||||
| Non-GAAP measures | $ | 91,164 | $ | 2.52 | $ | 87,650 | $ | 2.39 | $ | 273,165 | $ | 7.52 | $ | 236,579 | $ | 6.47 | |||||||||||||||||||||||||||||||
| Shares used in computing diluted net income per share (in thousands of shares) | |||||||||||||||||||||||||||||||||||||||||||||||
| GAAP diluted shares | 36,172 | 36,603 | 36,327 | 36,574 | |||||||||||||||||||||||||||||||||||||||||||
| Non-GAAP diluted shares | 36,172 | 36,603 | 36,327 | 36,574 | |||||||||||||||||||||||||||||||||||||||||||
| (in thousands of U.S. dollars) | Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||
| March 28, 2025 |
March 29, 2024 |
March 28, 2025 |
March 29, 2024 |
|||||||||||||||||||||||
| Net cash provided by operating activities | $ | 74,186 | $ | 100,870 | $ | 273,272 | $ | 330,084 | ||||||||||||||||||
| Less: Purchase of property, plant and equipment | (28,518) | (13,589) | (70,668) | (34,825) | ||||||||||||||||||||||
| Non-GAAP free cash flow | $ | 45,668 | $ | 87,281 | $ | 202,604 | $ | 295,259 | ||||||||||||||||||
|
Diluted
EPS
|
|||||
| GAAP net income per diluted share | $2.32 to $2.47 |
||||
| Related to cost of revenues: | |||||
| Share-based compensation expenses | 0.08 | ||||
| Total related to cost of revenues | 0.08 | ||||
| Related to selling, general and administrative expenses: | |||||
| Share-based compensation expenses | 0.15 | ||||
| Total related to selling, general and administrative expenses | 0.15 | ||||
| Total related to net income & EPS | 0.23 | ||||
| Non-GAAP net income per diluted share | $2.55 to $2.70 |
||||